Bradsaúde (SAUD3) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
21 May, 2026Executive summary
Revenues reached R$13.4 billion in 1Q26, with consolidated net income of R$1.3 billion and annualized ROAE of 24.8%, reflecting strong growth and scale in the healthcare ecosystem.
The ecosystem integrates health and dental insurance, hospitals, clinics, diagnostics, and technology, serving over 13 million beneficiaries nationwide.
Net additions totaled 193,000 in the quarter and 710,000 over the past 12 months, driven by commercial synergies and service expansion.
Major corporate restructuring completed, merging Bradesco Saúde, Odontoprev, and other assets under Bradsaúde, with the launch of the SAUD3 ticker.
Celebrated the launch of Bradsaúde's new IR website and new phase, highlighting integration and value generation over 20 years.
Financial highlights
Revenues reached R$13.4 billion in 1Q26, with net income of R$1.3 billion; Bradesco Saúde contributed 83%, Odontoprev 11%, Atlântica Hospitais 5%, and others 1%.
Financial assets totaled R$28.6 billion at the end of 1Q26, with financial results of R$875 million.
Written premiums for 1Q26 were R$13.3 billion, up 8.4% year-over-year; CAGR of 12.1% since 2021.
Odontoprev net revenue grew at a 15% CAGR since IPO, reaching R$2.4 billion in MAR26.
Net income for Odontoprev in 1Q26 was R$150.6 million, and for Bradesco Saúde R$914 million.
Outlook and guidance
Management remains cautious on claims ratio for 2026 due to seasonality, rising frequency, and medical inflation.
Continued expansion of hospital network with new openings scheduled through 2029, including Santa Lúcia Gama and Albert Einstein Vila Mariana.
Ongoing investments in technology, digital health, and innovation to enhance customer experience and operational efficiency.
Focus on sustainable cost management, price discipline, and long-term client retention.
Latest events from Bradsaúde
- Revenue up 5.3%, net income up 4.1%, 83% payout, and strong net cash with zero debt.SAUD3
Q4 20256 Jul 2026 - Record SME growth and margin expansion drove strong revenue and net income gains.SAUD3
Q3 20256 Jul 2026 - Net income up 18.1% YoY, record EBITDA margin, and robust SME-driven growth.SAUD3
Q2 20256 Jul 2026 - Adjusted EBITDA margin rose to 38.3% in 1Q25, led by SME and Individual plan growth.SAUD3
Q1 20256 Jul 2026 - Record net income and margin expansion driven by SME/Individual growth and strong cash position.SAUD3
Q3 20242 Jul 2026 - Revenue up 5.9%, net income R$539M, 97% payout, R$913M net cash, no debt.SAUD3
Q4 20242 Jul 2026 - 2Q24 delivered strong growth, record margins, and a 100% net income payout to shareholders.SAUD3
Q2 20242 Jul 2026 - High-margin, tech-focused dental insurer grows SME segment, sustains top dividends, and zero debt.SAUD3
Status update28 Jan 2026